Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis.
Dal Cero M, Bencivenga M, Liu DHW, Sacco M, Alloggio M, Kerckhoffs KGP, Filippini F, Saragoni L, Iglesias M, Tomezzoli A, Carneiro F, Grabsch HI, Verlato G, Torroni L, Piessen G, Pera M, de Manzoni G. Dal Cero M, et al. Among authors: saragoni l. Cancers (Basel). 2023 Oct 28;15(21):5191. doi: 10.3390/cancers15215191. Cancers (Basel). 2023. PMID: 37958365 Free PMC article. Review.
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT).
Paradiso A, Volpe S, Iacobacci A, Marubini E, Verderio P, Costa A, Daidone MG, Marchetti A, Mottolese M, Amadori D, De Paola F, Saragoni L, Medri L, Nenci I, Querzoli P, Gion M, Dittadi R, Plebani M, Orlando C, Bevilacqua G, Silvestrini R; Italian Network for Quality Assessment of Tumor Biomarkers. Paradiso A, et al. Among authors: saragoni l. Int J Biol Markers. 2002 Jul-Sep;17(3):201-14. doi: 10.1177/172460080201700310. Int J Biol Markers. 2002. PMID: 12408472 Free article.
[Multimodal treatment of gastric MALT lymphoma: our experience].
Curcio A, Bertelli R, Gentilini P, Ronconi S, Saragoni L, Vagliasindi A, Mura G, Mazza P, Framarini M, Verdecchia GM. Curcio A, et al. Among authors: saragoni l. Suppl Tumori. 2005 May-Jun;4(3):S77-8. Suppl Tumori. 2005. PMID: 16437915 Italian.
Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group.
Leoncini G, Donato F, Reggiani-Bonetti L, Salviato T, Cadei M, Daperno M, Principi MB, Armuzzi A, Caprioli F, Canavese G, Villanacci V; IG-IBD Pathology Group. Leoncini G, et al. Tech Coloproctol. 2021 Jan;25(1):101-108. doi: 10.1007/s10151-020-02349-9. Epub 2020 Oct 6. Tech Coloproctol. 2021. PMID: 33025294 Free article.
The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
Mangia A, Caldarola L, Dell'Endice S, Scarpi E, Saragoni L, Monti M, Santini D, Brunetti O, Simone G, Silvestris N. Mangia A, et al. Among authors: saragoni l. Cancer Biol Ther. 2015;16(8):1140-7. doi: 10.1080/15384047.2015.1056414. Epub 2015 Jun 30. Cancer Biol Ther. 2015. PMID: 26126066 Free PMC article.
Applicability of the Bethesda System 2001 to a public health setting.
Prandi S, Beccati D, De Aloysio G, Fulgenzi P, Gabrielli M, Ghirardini C, Rivasi F, Saragoni L, de Bianchi PS, Bucchi L. Prandi S, et al. Among authors: saragoni l. Cancer. 2006 Oct 25;108(5):271-6. doi: 10.1002/cncr.22167. Cancer. 2006. PMID: 16948127 Free article.
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.
Ulivi P, Capelli L, Valgiusti M, Zoli W, Scarpi E, Chiadini E, Rosetti P, Bravaccini S, Calistri D, Saragoni L, Casadei Gardini A, Ragazzini A, Frassineti GL, Amadori D, Passardi A. Ulivi P, et al. Among authors: saragoni l. J Transl Med. 2012 May 8;10:87. doi: 10.1186/1479-5876-10-87. J Transl Med. 2012. PMID: 22569004 Free PMC article.
126 results